Trial Profile
An Open Label, Randomized, Single Dose, Two-Way Crossover Bioequivalence Study Comparing A New 80 Mg Atorvastatin Tablet To A 80 Mg Atorvastatin Commercial Tablet In Healthy Subjects.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 22 Feb 2021
Price :
$35
*
At a glance
- Drugs Atorvastatin (Primary)
- Indications Alzheimer's disease; Atrial fibrillation; Cardiovascular disorders; Diabetic foot ulcer; Heart failure
- Focus Pharmacokinetics
- Sponsors Pfizer; Viatris
- 18 Jun 2009 New trial record